Fund Holdings — BML Capital Management, LLC

Total Portfolio Value
$112.98M
Total Bought
$17.72M
Total Sold
$26.43M
Net Transaction
-$8.70M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
ACLARIS THERAPEUTICS INC(ACRS)14,250,00014,250,000027,07542,89337.97%+15,818
CARMAX INC(KMX)0155,000+155,00005,9895.30%+5,989
ATEA PHARMACEUTICALS INC(AVIR)7,473,9637,490,000+16,03721,67426,73923.67%+5,065
TARGET CORP(TGT)10,00037,500+27,5008973,6663.24%+2,769
OUTSET MED INC(OM)0543,180+543,18002,0151.78%+2,015
PLIANT THERAPEUTICS INC(PLRX)01,546,137+1,546,13701,8861.67%+1,886
KEZAR LIFE SCIENCES INC
COM NEW
720,787720,78702,8114,5344.01%+1,723
ORAMED PHARMACEUTICALS INC(ORMP)3,167,2313,167,23108,3619,0277.99%+665
THIRD HARMONIC BIO INC3,824,4170-3,824,41700—0
MURAL ONCOLOGY PUB LTD CO57,5000-57,5001190—-119
LISATA THERAPEUTICS INC(LSTA)109,84173,348-36,4932881360.12%-151
IMAGENEBIO INC(IMA)182,509177,026-5,4831,4871,2211.08%-266
ARVINAS INC(ARVN)50,0000-50,0004260—-426
VISTAGEN THERAPEUTICS INC(VTGN)150,0000-150,0005330—-532
CONNECT BIOPHARMA HLDGS LTD(CNTB)1,267,500408,887-858,6131,9141,1531.02%-761
PMV PHARMACEUTICALS INC(PMVP)5,292,0005,292,00007,4096,6155.86%-794
ASTROTECH CORP220,4100-220,4101,0800—-1,080
ATHIRA PHARMA INC(LONA)323,0660-323,0661,3370—-1,337
LAVA THERAPEUTICS NV1,970,6100-1,970,6103,0740—-3,074
INSTIL BIO INC(TIL)645,600645,600011,5307,1026.29%-4,429
ALUMIS INC1,210,4150-1,210,4154,8300—-4,830
ADVERUM BIOTECHNOLOGIES INC3,057,5260-3,057,52613,8510—-13,851
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q4 2025 | TickerTrail